Valuation Ipsen

Stocks

Market Closed - Euronext Paris 11:55:00 2026-11-04 EST			5-day change	1st Jan Change
155.80 ^EUR	+1.70%		+2.16%	+30.92%

10-22	Ipsen: Better-than-expected Q3 overshadowed by 2027 Somatuline erosion and arbitration risk
10-22	Ipsen S.A. Upgrades Financial Guidance for the Full-Year 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,774	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	30.75%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,266	10,278	9,235
Change	-	16.81%	12.22%	1.81%	2.28%	22.12%	-8.77%	-10.15%
P/E	10.4x	12.9x	14x	26.7x	22.4x	11.3x	12.8x	13.4x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.6x	2.2x	1.9x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-1.1x	-3.04x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.78x	2.69x	2.63x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.45x	2.17x	1.9x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	5.58x	5.51x	5.02x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	6.54x	6.59x	6.14x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.15x	8.25x	7.29x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	10.9%	12.1%	13.7%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.431	1.553	1.447
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.92%	1%	0.93%
EPS ²	7.76	7.81	7.73	4.15	5.32	13.75	12.18	11.64
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	10.4%	12.8%	12.4%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,600	4,747	4,856
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	2,018	1,866	1,841
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,723	1,559	1,503
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,144	1,052	1,013
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,508	-2,496	-3,539
Reference price ²	80.50	100.50	107.90	110.70	119.00	155.80	155.80	155.80
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	2/11/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	11.14x	2.4x	5.48x	0.93%	14.06B
ELI LILLY AND COMPANY	41.24x	13.94x	30.97x	0.48%	1,255B
JOHNSON & JOHNSON	38.96x	6.55x	18.42x	2.01%	641B
ABBVIE INC.	36.79x	8.37x	17.26x	2.42%	505B
ROCHE HOLDING AG	21.08x	5.12x	12.75x	2.56%	381B
MERCK & CO., INC.	95.75x	5.88x	25.02x	2.35%	357B
NOVARTIS AG	22.88x	5.88x	14.19x	2.73%	303B
ASTRAZENECA PLC	24.26x	4.85x	13.68x	1.8%	286B
AMGEN INC.	29.25x	7.46x	13.36x	2.19%	249B
GILEAD SCIENCES, INC.	-40.09x	7.32x	45.96x	1.97%	208B
Average	28.13x	6.78x	19.71x	1.94%	419.93B
Weighted average by Cap.	35.85x	8.70x	22.47x	1.72%